CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current drug metabolism

• Publication date

  2008-08-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/138920008785821710PMID 18781911PMCID PMC2605793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacogenetics of the constitutive androstane receptor.

  2008cited by this paper
• Nuclear Receptor CAR Requires Early Growth Response 1 to Activate the Human Cytochrome P450 2B6 Gene*

  2008cited by this paper
• Cytochrome P450s in the development of target-based anticancer drugs.

  2008cited by this paper
• Improvement of Cyclophosphamide Activation by CYP2B6 Mutants: From in Silico to ex Vivo

  2008cited by this paper
• Stereoselective Bupropion Hydroxylation as an In Vivo Phenotypic Probe for Cytochrome P4502B6 (CYP2B6) Activity

  2008cited by this paper
• Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver

  2008cited by this paper
• CAR and PXR: the xenobiotic-sensing receptors.

  2007cited by this paper
• The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals.

  2007cited by this paper
• Expression and transcriptional activities of nuclear receptors involved in regulation of drug-metabolizing enzymes are not altered by colchicine: Focus on PXR, CAR, and GR in primary human hepatocytes

  2007cited by this paper
• Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients

  2007cited by this paper
• Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.

  2007cited by this paper
• Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers

  2007cited by this paper
• Inhibition of fipronil and nonane metabolism in human liver microsomes and human cytochrome P450 isoforms by chlorpyrifos

  2007cited by this paper
• Stereoselective Block of hERG Channel by (S)‐Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers

  2007cited by this paper
• A Randomized Controlled Trial of Therapeutic Drug Monitoring in Treatment-Naive and -Experienced HIV-1-Infected Patients

  2007cited by this paper
• In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase

  2007cited by this paper
• Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.

  2007cited by this paper
• Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

  2007cited by this paper
• A Comparison of 2-Phenyl-2-(1-piperidinyl)propane (PPP), 1,1′,1″-Phosphinothioylidynetrisaziridine (ThioTEPA), Clopidogrel, and Ticlopidine as Selective Inactivators of Human Cytochrome P450 2B6

  2007cited by this paper
• Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals

  2007cited by this paper
• Absence of CYP2B6 promoter −82T>C mutation in Chinese as an additional factor for slow metabolism of drugs commonly used in infections

  2006cited by this paper
• Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.

  2006cited by this paper
• Human genetic variability and HIV treatment response

  2006cited by this paper
• Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity

  2006cited by this paper
• Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance.

  2006cited by this paper
• Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.

  2006cited by this paper
• CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment.

  2006cited by this paper
• Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver.

  2006cited by this paper
• Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor

  2006cited by this paper
• Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.

  2006cited by this paper
• Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6

  2006cited by this paper
• Intra- and Inter-ethnic Differences in the Allele Frequencies of Cytochrome P450 2B6 Gene in Chinese

  2006cited by this paper
• Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver

  2006cited by this paper
• Induction of the hepatic cytochrome P450 2B subfamily by xenobiotics: research history, evolutionary aspect, relation to tumorigenesis, and mechanism.

  2006cited by this paper
• Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

  2006cited by this paper
• Cohesin protein SMC1 represses the nuclear receptor CAR-mediated synergistic activation of a human P450 gene by xenobiotics.

  2006cited by this paper
• AMP-activated Protein Kinase Mediates Phenobarbital Induction of CYP2B Gene Expression in Hepatocytes and a Newly Derived Human Hepatoma Cell Line*

  2005cited by this paper
• Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.

  2005cited by this paper
• Retinoid X Receptor-α-Dependent Transactivation by a Naturally Occurring Structural Variant of Human Constitutive Androstane Receptor (NR1I3)

  2005cited by this paper
• Therapeutic Drug Monitoring of Efavirenz: Trough Levels Cannot Be Estimated on the Basis of Earlier Plasma Determinations

  2005cited by this paper
• Gene nomenclature by default, or BLASTing to Babel

  2005cited by this paper
• Functional analysis of four naturally occurring variants of human constitutive androstane receptor.

  2005cited by this paper
• Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane Receptor

  2005cited by this paper
• Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

  2005cited by this paper
• Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs.

  2005cited by this paper
• CAR, the continuously advancing receptor, in drug metabolism and disease.

  2005cited by this paper
• Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz

  2005cited by this paper
• Novel CAR-mediated Mechanism for Synergistic Activation of Two Distinct Elements within the Human Cytochrome P450 2B6 Gene in HepG2 Cells*

  2005cited by this paper
• Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.

  2005cited by this paper
• A Natural CYP2B6 TATA Box Polymorphism (–82T→ C) Leading to Enhanced Transcription and Relocation of the Transcriptional Start Site

  2005cited by this paper
• Modulation of UDP‐glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers

  2005cited by this paper
• Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity

  2005cited by this paper
• Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

  2005cited by this paper
• Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

  2004cited by this paper
• Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study

  2004cited by this paper
• Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.

  2004cited by this paper
• Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism.

  2004cited by this paper
• The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

  2004cited by this paper
• Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.

  2004cited by this paper
• Human Constitutive Androstane Receptor Mediates Induction of CYP2B6 Gene Expression by Phenytoin*

  2004cited by this paper
• Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer

  2004cited by this paper
• Use of Replication-Conditional Adenovirus as a Helper System to Enhance Delivery of P450 Prodrug-Activation Genes for Cancer Therapy

  2004cited by this paper
• Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.

  2004cited by this paper
• CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.

  2004cited by this paper
• Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

  2004cited by this paper
• Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.

  2004cited by this paper
• Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

  2004cited by this paper
• The pregnane X receptor binds to response elements in a genomic context-dependent manner, and PXR activator rifampicin selectively alters the binding among target genes.

  2004cited by this paper
• CAR, driving into the future.

  2004cited by this paper
• Multiple Novel Nonsynonymous CYP2B6 Gene Polymorphisms in Caucasians: Demonstration of Phenotypic Null Alleles

  2004cited by this paper
• CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11

  2004cited by this paper
• Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation

  2003cited by this paper
• A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection.

  2003cited by this paper
• Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain.

  2003cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation.

  2003cited by this paper
• Alternatively spliced isoforms of the human constitutive androstane receptor.

  2003cited by this paper
• Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors.

  2003cited by this paper
• The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity

  2003cited by this paper
• Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes.

  2003cited by this paper
• Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression

  2003cited by this paper
• Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9

  2003cited by this paper
• Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes*

  2003cited by this paper
• Induction of bilirubin clearance by the constitutive androstane receptor (CAR)

  2003cited by this paper
• Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.

  2003cited by this paper
• A Novel Distal Enhancer Module Regulated by Pregnane X Receptor/Constitutive Androstane Receptor Is Essential for the Maximal Induction of CYP2B6 Gene Expression*

  2003cited by this paper
• Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes

  2003cited by this paper
• Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine

  2003cited by this paper
• Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems.

  2003cited by this paper
• Enantioselective metabolism of the endocrine disruptor pesticide methoxychlor by human cytochromes P450 (P450s): major differences in selective enantiomer formation by various P450 isoforms.

  2002cited by this paper
• Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.

  2002cited by this paper
• Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site.

  2002cited by this paper
• Summary of information on human CYP enzymes: human P450 metabolism data

  2002cited by this paper
• The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.

  2002cited by this paper
• Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite.

  2002cited by this paper
• The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes.

  2002cited by this paper
• Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes.

  2002cited by this paper
• [Therapy-related acute myeloid leukemia following double autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma].

  2002cited by this paper
• Species-specific responses of constitutively active receptor (CAR)-CYP2B coupling: lack of CYP2B inducer-responsive nuclear translocation of CAR in marine teleost, scup (Stenotomus chrysops).

  2002cited by this paper
• Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification.

  2002cited by this paper

• Induction of human cytochrome P450 enzymes activity by metabolism disrupting chemicals in the human hepatic cell line HepaRG.

  2025cites this paper
• Mechanisms of altered hepatic drug disposition during pregnancy: small molecules

  2025cites this paper
• Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases

  2025cites this paper
• CYP2B6*6 single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: implications on efficacy of artemether-lumefantrine

  2025cites this paper
• Canine duodenal organoids as a functional platform for intestinal CYP regulation and drug metabolism studies

  2025cites this paper
• CYP2B6*6 single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: Implications on efficacy of artemether-lumefantrine

  2025cites this paper
• The causal role of endocrine disrupting chemicals in pubertal timing: a Mendelian randomization study

  2025cites this paper
• Analysis of 1,25-dihydroxyvitamin D genomic action in human enteroids and colonoids reveals multiple regulatory effects of vitamin D in human intestinal physiology

  2025influential citation
• Functional significance of CYP2B6 gene rare allelic variants identified in Japanese individuals.

  2024cites this paper
• Increased Perfluorooctanesulfonate (PFOS) Toxicity and Accumulation Is Associated with Perturbed Prostaglandin Metabolism and Increased Organic Anion Transport Protein (OATP) Expression

  2024cites this paper
• 9-HODE and 9-HOTrE alter mitochondrial metabolism, increase triglycerides, and perturb fatty acid uptake and synthesis associated gene expression in HepG2 cells.

  2024cites this paper
• A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B6.

  2024cites this paper
• Allelic and Genotype Frequencies of CYP2B6∗2 (64C > T) and CYP2B6∗3 (777C > A) in Three Dominant Ethnicities of the Iranian Population

  2023cites this paper
• Allelic variants of CYP2B6 gene expression and its implication on the pathogenesis of malaria among a cohort of outpatients in North-Central Nigeria

  2023cites this paper
• Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications

  2023cites this paper
• Genetic polymorphisms of CYP2B6*6, CYP2C8*3 and CYP2D6*4 in vivax malaria patients from Brazilian Amazon

  2023cites this paper
• Quantitative Prediction of Drug Interactions Caused by Cytochrome P450 2B6 Inhibition or Induction

  2022cites this paper
• Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy

  2022cites this paper
• Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction

  2022cites this paper
• Multidisciplinary Insights into the Structure–Function Relationship of the CYP2B6 Active Site

  2022influential citation
• Dataset of endo- and xenobiotic inhibition of CYP2B6: Comparison to CYP3A4

  2022cites this paper
• R G I A N E D I C A L E W S

  2022cites this paper
• Adenosine N6-methylation upregulates the expression of human CYP2B6 by altering the chromatin status.

  2022cites this paper
• ACTIVATION OF THE PPAR NUCLEAR RECEPTORS BY OXYLIPINS AND THEIR POTENTIAL EFFECTS ON DIFFERENTIATION AND GENE EXPRESSION IN MYOCYTES

  2022influential citation
• Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy

  2022cites this paper
• Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression

  2021influential citation
• Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail

  2021cites this paper
• In vitro effects of 95% khat ethanol extract (KEE) on human recombinant cytochrome P450 (CYP)1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2 and CYP3A5

  2021cites this paper
• PharmVar GeneFocus: CYP2B6

  2021cites this paper
• In Silico Structural, Functional, and Phylogenetic Analysis of Cytochrome (CYPD) Protein Family

  2021cites this paper
• Sex-Biased Expression of Pharmacogenes across Human Tissues

  2021cites this paper
• Paroxetine—Overview of the Molecular Mechanisms of Action

  2021cites this paper
• Increased toxicity and retention of Perflourooctane Sulfonate (PFOS) in humanized CYP2B6-Transgenic mice compared to Cyp2b-null mice is relieved by a High-Fat Diet (HFD).

  2021cites this paper
• Distinct contribution of hyperbaric oxygen therapy to human neutrophil function and antibiotic efficacy against Staphylococcus aureus

  2021cites this paper
• Hot and Cold Theory: Evidence in Systems Biology.

  2021cites this paper
• Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes

  2021cites this paper
• Effect of CYP2C9 genetic polymorphism and breviscapine on losartan pharmacokinetics in healthy subjects

  2021cites this paper
• mmu-miR-199a-5p regulates CYP2B10 through repression of E4BP4 in mouse AML-12 hepatocytes

  2021cites this paper
• Can Eucalyptol Replace Antibiotics?

  2021cites this paper
• Frequencies of CYP2B6∗4,∗5, and ∗6 Alleles within an Iranian Population (Mazandaran)

  2021cites this paper
• Allelic and genotype frequencies of major CYP2B6 polymorphisms in the Pakistani population

  2021cites this paper
• Identification of miRNAs that regulate human CYP2B6 expression.

  2021cites this paper
• Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care.

  2020cites this paper
• Ontogeny and Cross-species Comparison of Pathways Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Neonates (Review): Kidney

  2020cites this paper
• Gender differences in diet-induced steatotic disease in Cyp2b-null mice

  2020cites this paper
• Expression of cytochrome P450 isozyme transcripts and activities in human livers

  2020cites this paper
• Tethered primary hepatocyte spheroids on polystyrene multi-well plates for high-throughput drug safety testing

  2020cites this paper
• Characterization of CYP2B6 K262R allelic variants by quantitative allele-specific proteomics using a QconCAT standard.

  2020cites this paper
• Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail

  2020influential citation
• How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?

  2020cites this paper
• Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

  2020cites this paper
• Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis

  2020cites this paper
• Circulating miRNAs as Biomarkers for CYP2B6 Enzyme Activity

  2020cites this paper
• The atorvastatin metabolic phenotype shift is influenced by interaction of drug-transporter polymorphisms in Mexican population: results of a randomized trial

  2020cites this paper
• NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition

  2020cites this paper
• Pharmacogenomics and Psychopharmacology

  2020cites this paper
• CYP2B6 Polymorphisms Are Associated with Ischemic Stroke Risk in a Chinese Han Population

  2020cites this paper
• Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes

  2019cites this paper
• microRNA-605 rs2043556 polymorphisms affect clopidogrel therapy through modulation of CYP2B6 and P2RY12 in acute coronary syndrome patients

  2019cites this paper
• Role of cytochrome P450 2B6 polymorphisms in unexpected methadone death

  2019cites this paper
• Polymorphisms that affect propofol metabolism and their clinical effects

  2019cites this paper
• Principles of Pharmacogenomics

  2019cites this paper
• Nitrogen Mustards As Anticancer Chemotherapies: Historic Perspective, Current Developments, And Future Trends.

  2019cites this paper
• Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study

  2019cites this paper
• Methadone Disposition: Implementing Lessons Learned

  2019cites this paper
• Methadone serum concentrations and influencing factors: A naturalistic observational study

  2019cites this paper
• Constitutive androstane receptor mediates pcb-induced disruption of retinoid homeostasis.

  2019cites this paper
• Inhibition of cytochrome P450 2B6 by Astragalus extract mixture HT042

  2019cites this paper
• CYP2B6*6 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers

  2019cites this paper
• Marmoset cytochrome P450 2B6, a propofol hydroxylase expressed in liver

  2019cites this paper
• Molecular simulation study of CYP2B6 polymorphism with and without psoralen

  2018cites this paper
• A CYP2B6-humanized mouse model and its potential applications.

  2018cites this paper
• Association of CYP2B6 ( G15631T ) polymorphism with Clopidogrel resistance and genetic predisposition to Acute Coronary Syndromes (ACSs) in Morocco

  2018cites this paper
• Towards personalized opioid dosing: A concise overview of CYP polymorphisms

  2018cites this paper
• Halogen Substitution Influences Ketamine Metabolism by Cytochrome P450 2B6: In Vitro and Computational Approaches.

  2018cites this paper
• Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims

  2018cites this paper
• The impact of CYP2B6 polymorphisms on the interactions of efavirenz with lumefantrine: Implications for paediatric antimalarial therapy

  2018cites this paper
• Are Cyp2b and Cyp3a Important in Hepatic Lipid Metabolism

  2018cites this paper
• Complex gene expansion of the CYP2D gene subfamily

  2018cites this paper
• Cyp2b-Knockdown Mice Poorly Metabolize Corn Oil and Are Age-Dependent Obese.

  2018cites this paper
• Regulation of cytochrome P450 gene expression by ketamine: a review

  2018cites this paper
• Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approach.

  2018cites this paper
• Role of xenobiotics in the induction and progression of fatty liver disease.

  2018cites this paper
• Health-Relevant Phenotypes in the Offspring of Mice Given CAR Activators Prior to Pregnancy

  2018cites this paper
• Cytochrome P450 Induction and Xeno‐Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator‐Activated Receptor &agr; at the Crossroads of Toxicokinetics and Toxicodynamics

  2018cites this paper
• Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics

  2018cites this paper
• Inhibitory effect of α-terpinyl acetate on cytochrome P450 2B6 enzymatic activity.

  2018cites this paper
• Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safety

  2018cites this paper
• Cytochrome P450 in Pharmacogenetics: An Update.

  2018cites this paper
• Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view

  2018cites this paper
• CYP2B6*6 Screening; Potential Benefits and Challenges in HIV Therapy in Sub-Saharan Africa

  2017cites this paper
• Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.

  2017cites this paper
• Effect of genetic polymorphism of human CYP2B6 on the metabolic activation of chlorpyrifos.

  2017cites this paper
• Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs

  2017cites this paper
• Tetrabromobisphenol A activates the hepatic interferon pathway in rats.

  2017cites this paper
• Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer

  2017cites this paper
• Hepatocyte CYP2B6 Can Be Expressed in Cell Culture Systems by Exerting Physiological Levels of Shear: Implications for ADME Testing

  2017cites this paper
• Biochemical and Histological Evaluation of Kidney Function in Rats after a Single Administration of Cyclophosphamide and Ifosfamide

  2017cites this paper
• Effect of breviscapine on CYP3A metabolic activity in healthy volunteers

  2017cites this paper
• Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers

  2017influential citation